Share Price and Basic Stock Data
Last Updated: October 17, 2025, 9:27 pm
| PEG Ratio | -39.68 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Linde India Ltd operates within the industrial gases sector, reporting a share price of ₹6,178 and a market capitalization of ₹52,694 Cr. The company has shown a robust revenue trajectory, with sales recorded at ₹3,136 Cr for the twelve months ending March 2023, which subsequently declined to ₹2,769 Cr in March 2024 and further to ₹2,485 Cr in March 2025. The quarterly sales figures indicate fluctuations, with a peak of ₹721 Cr in June 2023, followed by a slight decrease to ₹711 Cr in September 2023. Year-on-year sales performance has been influenced by varying operational conditions, with the operating profit margin (OPM) standing at 24% for the twelve months ending March 2023 and improving to 31% by March 2025. The company’s ability to navigate market challenges while maintaining significant sales levels highlights its operational resilience.
Profitability and Efficiency Metrics
Linde India’s profitability metrics reflect a mixed performance. The net profit for the twelve months ending March 2025 was reported at ₹448 Cr, which was a decline from ₹536 Cr in March 2023 and ₹426 Cr in March 2024. The earnings per share (EPS) also reflected this trend, standing at ₹52.51 in March 2025, down from ₹62.82 in March 2023. Despite these declines, the return on equity (ROE) and return on capital employed (ROCE) were reported at 12.3% and 16.9%, respectively, indicating a reasonable return on investment. The interest coverage ratio (ICR) is notably strong at 147.29x, suggesting that the company can easily meet its interest obligations. The cash conversion cycle stood at -224 days, reflecting efficient management of working capital, which can be seen as a significant strength in maintaining liquidity.
Balance Sheet Strength and Financial Ratios
Linde India’s balance sheet reveals a solid structure with total reserves amounting to ₹3,694 Cr against borrowings of merely ₹42 Cr, suggesting a low debt profile and a debt-to-equity ratio that is significantly favorable. The company’s total assets stood at ₹5,110 Cr, providing a strong asset base for operations. The liquidity ratios also reflect a healthy position, with a current ratio of 1.88x and a quick ratio of 1.80x, indicating adequate short-term liquidity. Additionally, the price-to-book value (P/BV) ratio of 9.62x suggests that the stock might be overvalued compared to its book value, which could deter some value-oriented investors. Overall, the financial ratios indicate a robust balance sheet that supports operational stability and growth potential.
Shareholding Pattern and Investor Confidence
The shareholding structure of Linde India indicates strong promoter confidence, with promoters holding 75% of the total shares. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) accounted for 2.51% and 6.62%, respectively, reflecting moderate institutional interest. The public shareholding stood at 15.87%, with the number of shareholders increasing to 68,796, which suggests growing retail investor interest. However, the declining trend in FII participation from 2.89% in September 2023 to 2.51% in June 2025 could raise concerns regarding foreign investor confidence. The consistent promoter holding combined with a steady increase in public shareholders indicates a stable foundation for future growth, although fluctuations in institutional ownership may warrant closer scrutiny.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies are maintained, Linde India could capitalize on its strong market position within the industrial gases sector. However, risks such as declining net profits and fluctuating sales figures pose challenges to its growth trajectory. The increasing operational costs and potential market volatility could impact profitability, necessitating vigilant cost management. Additionally, while the strong balance sheet offers resilience, the high P/BV ratio may limit upside potential for value investors. Should the company navigate these challenges effectively while capitalizing on emerging market opportunities, it could enhance shareholder value and stabilize its profitability metrics in the coming quarters.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Linde India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gagan Gases Ltd | 12.2 Cr. | 26.9 | 35.8/17.6 | 57.9 | 7.33 | 0.00 % | 10.6 % | 8.49 % | 10.0 |
| Bhagawati Oxygen Ltd | 9.98 Cr. | 43.2 | 72.3/36.3 | 17.2 | 0.00 % | 6.68 % | 10.6 % | 10.0 | |
| Refex Industries Ltd | 4,498 Cr. | 347 | 575/334 | 24.1 | 96.8 | 0.14 % | 25.3 % | 22.0 % | 2.00 |
| Linde India Ltd | 52,470 Cr. | 6,154 | 8,470/5,202 | 119 | 443 | 0.07 % | 16.9 % | 12.3 % | 10.0 |
| Industry Average | 28,484.00 Cr | 1,642.78 | 67.00 | 141.08 | 0.05% | 14.87% | 13.35% | 8.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 588 | 686 | 697 | 630 | 721 | 711 | 706 | 630 | 653 | 634 | 606 | 592 | 571 |
| Expenses | 453 | 542 | 529 | 444 | 557 | 538 | 520 | 452 | 469 | 456 | 414 | 382 | 374 |
| Operating Profit | 135 | 144 | 168 | 186 | 164 | 174 | 186 | 179 | 184 | 179 | 192 | 210 | 197 |
| OPM % | 23% | 21% | 24% | 30% | 23% | 24% | 26% | 28% | 28% | 28% | 32% | 35% | 34% |
| Other Income | 11 | 35 | 28 | 22 | 18 | 19 | 22 | 18 | 19 | 16 | 19 | 13 | 4 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 4 | 2 | 2 | 2 | 7 | 3 |
| Depreciation | 46 | 47 | 48 | 66 | 49 | 50 | 51 | 52 | 51 | 52 | 55 | 56 | 56 |
| Profit before tax | 98 | 130 | 146 | 140 | 132 | 141 | 156 | 141 | 150 | 141 | 155 | 161 | 142 |
| Tax % | -72% | 30% | 23% | 30% | 26% | 24% | 25% | 26% | 25% | 26% | 26% | 27% | 26% |
| Net Profit | 169 | 91 | 113 | 99 | 98 | 107 | 117 | 104 | 112 | 104 | 114 | 118 | 105 |
| EPS in Rs | 19.84 | 10.64 | 13.27 | 11.58 | 11.51 | 12.51 | 13.74 | 12.23 | 13.08 | 12.24 | 13.37 | 13.82 | 12.32 |
Last Updated: August 20, 2025, 7:40 am
Below is a detailed analysis of the quarterly data for Linde India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 571.00 Cr.. The value appears to be declining and may need further review. It has decreased from 592.00 Cr. (Mar 2025) to 571.00 Cr., marking a decrease of 21.00 Cr..
- For Expenses, as of Jun 2025, the value is 374.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 382.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 197.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 197.00 Cr., marking a decrease of 13.00 Cr..
- For OPM %, as of Jun 2025, the value is 34.00%. The value appears to be declining and may need further review. It has decreased from 35.00% (Mar 2025) to 34.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 9.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 56.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 105.00 Cr.. The value appears to be declining and may need further review. It has decreased from 118.00 Cr. (Mar 2025) to 105.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 12.32. The value appears to be declining and may need further review. It has decreased from 13.82 (Mar 2025) to 12.32, marking a decrease of 1.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:56 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,428 | 1,491 | 1,567 | 1,825 | 2,033 | 2,192 | 1,762 | 1,471 | 2,112 | 3,136 | 2,769 | 2,485 | 2,403 |
| Expenses | 1,167 | 1,214 | 1,337 | 1,539 | 1,705 | 1,866 | 1,347 | 1,096 | 1,564 | 2,371 | 2,066 | 1,720 | 1,625 |
| Operating Profit | 261 | 277 | 230 | 287 | 328 | 326 | 415 | 375 | 548 | 765 | 702 | 765 | 778 |
| OPM % | 18% | 19% | 15% | 16% | 16% | 15% | 24% | 25% | 26% | 24% | 25% | 31% | 32% |
| Other Income | 59 | 11 | 22 | 34 | 11 | 23 | 862 | 44 | 348 | 109 | 77 | 68 | 53 |
| Interest | 74 | 103 | 90 | 116 | 116 | 103 | 86 | 6 | 3 | 6 | 7 | 13 | 14 |
| Depreciation | 129 | 181 | 162 | 195 | 206 | 199 | 177 | 176 | 181 | 253 | 201 | 214 | 218 |
| Profit before tax | 117 | 4 | 1 | 10 | 16 | 47 | 1,013 | 236 | 711 | 614 | 571 | 606 | 599 |
| Tax % | 34% | -51% | -4,164% | -31% | -17% | 29% | 28% | 34% | 28% | 13% | 25% | 26% | |
| Net Profit | 77 | 5 | 23 | 13 | 19 | 33 | 727 | 156 | 514 | 536 | 426 | 448 | 441 |
| EPS in Rs | 9.07 | 0.63 | 2.75 | 1.57 | 2.22 | 3.93 | 85.27 | 18.24 | 60.26 | 62.82 | 49.99 | 52.51 | 51.75 |
| Dividend Payout % | 17% | 237% | 27% | 48% | 45% | 38% | 12% | 16% | 22% | 19% | 24% | 23% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 5.16% |
| Change in YoY Net Profit Growth (%) | 0.00% |
Linde India Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | 6% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 92% |
| 5 Years: | 30% |
| 3 Years: | 14% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 55% |
| 3 Years: | 24% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 9:50 am
Balance Sheet
Last Updated: June 16, 2025, 11:47 am
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
| Reserves | 1,342 | 1,304 | 1,307 | 1,310 | 1,322 | 1,342 | 2,052 | 2,118 | 2,606 | 3,029 | 3,349 | 3,694 |
| Borrowings | 1,528 | 1,564 | 1,388 | 1,445 | 1,282 | 1,199 | 108 | 7 | 24 | 22 | 21 | 42 |
| Other Liabilities | 1,011 | 926 | 883 | 722 | 680 | 759 | 970 | 1,048 | 1,287 | 1,246 | 1,324 | 1,289 |
| Total Liabilities | 3,966 | 3,880 | 3,664 | 3,563 | 3,369 | 3,385 | 3,215 | 3,259 | 4,003 | 4,382 | 4,780 | 5,110 |
| Fixed Assets | 1,665 | 2,201 | 2,158 | 2,573 | 2,498 | 2,162 | 2,035 | 1,989 | 1,869 | 1,762 | 1,822 | 1,925 |
| CWIP | 744 | 356 | 577 | 80 | 36 | 44 | 53 | 17 | 68 | 225 | 483 | 975 |
| Investments | 15 | 15 | 15 | 15 | 15 | 0 | 0 | 2 | 2 | 16 | 27 | 27 |
| Other Assets | 1,542 | 1,308 | 915 | 895 | 821 | 1,179 | 1,127 | 1,251 | 2,064 | 2,378 | 2,448 | 2,183 |
| Total Assets | 3,966 | 3,880 | 3,664 | 3,563 | 3,369 | 3,385 | 3,215 | 3,259 | 4,003 | 4,382 | 4,780 | 5,110 |
Below is a detailed analysis of the balance sheet data for Linde India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 85.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 85.00 Cr..
- For Reserves, as of Mar 2025, the value is 3,694.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,349.00 Cr. (Mar 2024) to 3,694.00 Cr., marking an increase of 345.00 Cr..
- For Borrowings, as of Mar 2025, the value is 42.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 21.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 21.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,289.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,324.00 Cr. (Mar 2024) to 1,289.00 Cr., marking a decrease of 35.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 5,110.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,780.00 Cr. (Mar 2024) to 5,110.00 Cr., marking an increase of 330.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,925.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,822.00 Cr. (Mar 2024) to 1,925.00 Cr., marking an increase of 103.00 Cr..
- For CWIP, as of Mar 2025, the value is 975.00 Cr.. The value appears strong and on an upward trend. It has increased from 483.00 Cr. (Mar 2024) to 975.00 Cr., marking an increase of 492.00 Cr..
- For Investments, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,183.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,448.00 Cr. (Mar 2024) to 2,183.00 Cr., marking a decrease of 265.00 Cr..
- For Total Assets, as of Mar 2025, the value is 5,110.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,780.00 Cr. (Mar 2024) to 5,110.00 Cr., marking an increase of 330.00 Cr..
Notably, the Reserves (3,694.00 Cr.) exceed the Borrowings (42.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 260.00 | 276.00 | 229.00 | 286.00 | 327.00 | 325.00 | 307.00 | 368.00 | 524.00 | 765.00 | 681.00 | 723.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 75 | 78 | 71 | 63 | 61 | 79 | 101 | 73 | 47 | 63 | 57 |
| Inventory Days | 104 | 153 | 141 | 102 | 91 | 66 | 57 | 72 | 37 | 22 | 32 | 69 |
| Days Payable | 424 | 541 | 466 | 447 | 348 | 293 | 327 | 477 | 312 | 156 | 235 | 349 |
| Cash Conversion Cycle | -246 | -313 | -247 | -274 | -194 | -166 | -190 | -303 | -202 | -87 | -139 | -224 |
| Working Capital Days | -66 | -81 | 16 | -70 | -69 | -81 | -22 | 6 | -3 | -9 | -12 | -29 |
| ROCE % | 5% | 3% | 3% | 4% | 5% | 6% | 11% | 10% | 17% | 21% | 17% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Kotak Equity Opportunities Fund - Regular Plan | 814,736 | 3.2 | 488.42 | 814,736 | 2025-04-22 17:25:28 | 0% |
| Axis Midcap Fund | 461,771 | 1.26 | 276.82 | 461,771 | 2025-04-22 17:25:28 | 0% |
| Kotak ELSS Tax Saver Fund | 200,000 | 2.91 | 119.9 | 200,000 | 2025-04-22 17:25:28 | 0% |
| Axis Growth Opportunities Fund | 180,617 | 1.13 | 108.28 | 180,617 | 2025-04-22 17:25:28 | 0% |
| DSP Mid Cap Fund | 168,397 | 0.7 | 100.95 | 168,397 | 2025-04-22 17:25:28 | 0% |
| Axis Special Situations Fund | 91,942 | 4.61 | 55.12 | 91,942 | 2025-04-22 17:25:28 | 0% |
| Kotak ESG Opportunities Fund | 67,000 | 4.22 | 40.17 | 67,000 | 2025-04-22 17:25:28 | 0% |
| Canara Robeco Mid Cap Fund | 65,450 | 2.43 | 39.24 | 65,450 | 2025-04-22 17:25:28 | 0% |
| Aditya Birla Sun Life MNC Fund - Div | 23,789 | 0.43 | 14.26 | 23,789 | 2025-04-22 17:25:28 | 0% |
| Aditya Birla Sun Life MNC Fund - Gr | 23,789 | 0.43 | 14.26 | 23,789 | 2025-04-22 17:25:28 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 53.33 | 50.90 | 63.09 | 51.45 | 59.47 |
| Diluted EPS (Rs.) | 53.33 | 50.90 | 63.09 | 51.45 | 59.47 |
| Cash EPS (Rs.) | 77.58 | 73.55 | 91.73 | 72.44 | 80.08 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 447.91 | 406.69 | 368.19 | 356.45 | 318.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 447.91 | 406.69 | 368.19 | 356.45 | 318.33 |
| Revenue From Operations / Share (Rs.) | 291.42 | 324.64 | 367.66 | 293.76 | 247.64 |
| PBDIT / Share (Rs.) | 97.67 | 91.38 | 101.80 | 77.47 | 70.50 |
| PBIT / Share (Rs.) | 72.59 | 67.82 | 72.15 | 55.54 | 49.23 |
| PBT / Share (Rs.) | 71.11 | 66.97 | 71.48 | 55.01 | 81.17 |
| Net Profit / Share (Rs.) | 52.51 | 49.99 | 62.08 | 50.50 | 58.81 |
| NP After MI And SOA / Share (Rs.) | 53.33 | 50.90 | 63.09 | 51.45 | 59.47 |
| PBDIT Margin (%) | 33.51 | 28.14 | 27.68 | 26.37 | 28.46 |
| PBIT Margin (%) | 24.90 | 20.89 | 19.62 | 18.90 | 19.88 |
| PBT Margin (%) | 24.40 | 20.62 | 19.44 | 18.72 | 32.77 |
| Net Profit Margin (%) | 18.01 | 15.39 | 16.88 | 17.19 | 23.75 |
| NP After MI And SOA Margin (%) | 18.30 | 15.67 | 17.16 | 17.51 | 24.01 |
| Return on Networth / Equity (%) | 11.90 | 12.51 | 17.13 | 14.43 | 18.68 |
| Return on Capital Employeed (%) | 15.04 | 15.32 | 17.75 | 14.04 | 13.36 |
| Return On Assets (%) | 8.84 | 9.03 | 12.22 | 9.98 | 12.62 |
| Asset Turnover Ratio (%) | 0.49 | 0.60 | 0.74 | 0.59 | 0.58 |
| Current Ratio (X) | 0.96 | 1.88 | 2.21 | 2.10 | 2.13 |
| Quick Ratio (X) | 0.86 | 1.80 | 2.13 | 2.02 | 2.06 |
| Inventory Turnover Ratio (X) | 25.93 | 6.84 | 11.26 | 9.32 | 5.71 |
| Dividend Payout Ratio (NP) (%) | 22.50 | 23.57 | 21.39 | 0.00 | 5.04 |
| Dividend Payout Ratio (CP) (%) | 15.30 | 16.11 | 14.55 | 0.00 | 3.71 |
| Earning Retention Ratio (%) | 77.50 | 76.43 | 78.61 | 0.00 | 94.96 |
| Cash Earning Retention Ratio (%) | 84.70 | 83.89 | 85.45 | 0.00 | 96.29 |
| Interest Coverage Ratio (X) | 65.96 | 107.21 | 153.50 | 147.29 | 196.87 |
| Interest Coverage Ratio (Post Tax) (X) | 36.46 | 59.65 | 94.60 | 97.01 | 75.05 |
| Enterprise Value (Cr.) | 53159.63 | 53673.99 | 33189.90 | 27993.22 | 20254.57 |
| EV / Net Operating Revenue (X) | 21.39 | 19.39 | 10.59 | 11.17 | 9.59 |
| EV / EBITDA (X) | 63.82 | 68.87 | 38.23 | 42.37 | 33.69 |
| MarketCap / Net Operating Revenue (X) | 21.45 | 19.74 | 10.97 | 11.67 | 10.06 |
| Retention Ratios (%) | 77.49 | 76.42 | 78.60 | 0.00 | 94.95 |
| Price / BV (X) | 13.95 | 15.76 | 10.95 | 9.62 | 7.82 |
| Price / Net Operating Revenue (X) | 21.45 | 19.74 | 10.97 | 11.67 | 10.06 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
After reviewing the key financial ratios for Linde India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 53.33. This value is within the healthy range. It has increased from 50.90 (Mar 24) to 53.33, marking an increase of 2.43.
- For Diluted EPS (Rs.), as of Mar 25, the value is 53.33. This value is within the healthy range. It has increased from 50.90 (Mar 24) to 53.33, marking an increase of 2.43.
- For Cash EPS (Rs.), as of Mar 25, the value is 77.58. This value is within the healthy range. It has increased from 73.55 (Mar 24) to 77.58, marking an increase of 4.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 447.91. It has increased from 406.69 (Mar 24) to 447.91, marking an increase of 41.22.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 447.91. It has increased from 406.69 (Mar 24) to 447.91, marking an increase of 41.22.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 291.42. It has decreased from 324.64 (Mar 24) to 291.42, marking a decrease of 33.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 97.67. This value is within the healthy range. It has increased from 91.38 (Mar 24) to 97.67, marking an increase of 6.29.
- For PBIT / Share (Rs.), as of Mar 25, the value is 72.59. This value is within the healthy range. It has increased from 67.82 (Mar 24) to 72.59, marking an increase of 4.77.
- For PBT / Share (Rs.), as of Mar 25, the value is 71.11. This value is within the healthy range. It has increased from 66.97 (Mar 24) to 71.11, marking an increase of 4.14.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 52.51. This value is within the healthy range. It has increased from 49.99 (Mar 24) to 52.51, marking an increase of 2.52.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 53.33. This value is within the healthy range. It has increased from 50.90 (Mar 24) to 53.33, marking an increase of 2.43.
- For PBDIT Margin (%), as of Mar 25, the value is 33.51. This value is within the healthy range. It has increased from 28.14 (Mar 24) to 33.51, marking an increase of 5.37.
- For PBIT Margin (%), as of Mar 25, the value is 24.90. This value exceeds the healthy maximum of 20. It has increased from 20.89 (Mar 24) to 24.90, marking an increase of 4.01.
- For PBT Margin (%), as of Mar 25, the value is 24.40. This value is within the healthy range. It has increased from 20.62 (Mar 24) to 24.40, marking an increase of 3.78.
- For Net Profit Margin (%), as of Mar 25, the value is 18.01. This value exceeds the healthy maximum of 10. It has increased from 15.39 (Mar 24) to 18.01, marking an increase of 2.62.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.30. This value is within the healthy range. It has increased from 15.67 (Mar 24) to 18.30, marking an increase of 2.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.90. This value is below the healthy minimum of 15. It has decreased from 12.51 (Mar 24) to 11.90, marking a decrease of 0.61.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has decreased from 15.32 (Mar 24) to 15.04, marking a decrease of 0.28.
- For Return On Assets (%), as of Mar 25, the value is 8.84. This value is within the healthy range. It has decreased from 9.03 (Mar 24) to 8.84, marking a decrease of 0.19.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.49. It has decreased from 0.60 (Mar 24) to 0.49, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1.5. It has decreased from 1.88 (Mar 24) to 0.96, marking a decrease of 0.92.
- For Quick Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has decreased from 1.80 (Mar 24) to 0.86, marking a decrease of 0.94.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 25.93. This value exceeds the healthy maximum of 8. It has increased from 6.84 (Mar 24) to 25.93, marking an increase of 19.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.50. This value is within the healthy range. It has decreased from 23.57 (Mar 24) to 22.50, marking a decrease of 1.07.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.30. This value is below the healthy minimum of 20. It has decreased from 16.11 (Mar 24) to 15.30, marking a decrease of 0.81.
- For Earning Retention Ratio (%), as of Mar 25, the value is 77.50. This value exceeds the healthy maximum of 70. It has increased from 76.43 (Mar 24) to 77.50, marking an increase of 1.07.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.70. This value exceeds the healthy maximum of 70. It has increased from 83.89 (Mar 24) to 84.70, marking an increase of 0.81.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 65.96. This value is within the healthy range. It has decreased from 107.21 (Mar 24) to 65.96, marking a decrease of 41.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.46. This value is within the healthy range. It has decreased from 59.65 (Mar 24) to 36.46, marking a decrease of 23.19.
- For Enterprise Value (Cr.), as of Mar 25, the value is 53,159.63. It has decreased from 53,673.99 (Mar 24) to 53,159.63, marking a decrease of 514.36.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 21.39. This value exceeds the healthy maximum of 3. It has increased from 19.39 (Mar 24) to 21.39, marking an increase of 2.00.
- For EV / EBITDA (X), as of Mar 25, the value is 63.82. This value exceeds the healthy maximum of 15. It has decreased from 68.87 (Mar 24) to 63.82, marking a decrease of 5.05.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 21.45. This value exceeds the healthy maximum of 3. It has increased from 19.74 (Mar 24) to 21.45, marking an increase of 1.71.
- For Retention Ratios (%), as of Mar 25, the value is 77.49. This value exceeds the healthy maximum of 70. It has increased from 76.42 (Mar 24) to 77.49, marking an increase of 1.07.
- For Price / BV (X), as of Mar 25, the value is 13.95. This value exceeds the healthy maximum of 3. It has decreased from 15.76 (Mar 24) to 13.95, marking a decrease of 1.81.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 21.45. This value exceeds the healthy maximum of 3. It has increased from 19.74 (Mar 24) to 21.45, marking an increase of 1.71.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Linde India Ltd:
- Net Profit Margin: 18.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.04% (Industry Average ROCE: 14.87%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.9% (Industry Average ROE: 13.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 36.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.86
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 119 (Industry average Stock P/E: 67)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industrial Gases | Oxygen House, P43, Taratala Road, Kolkata West Bengal 700088 | contact.lg.in@linde.com http://www.linde.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Michael J Devine | Chairman |
| Mr. Abhijit Banerjee | Managing Director |
| Ms. Shalini Sarin | Independent Director |
| Mr. Mannu Sanganeria | Non Executive Director |
| Mr. Subba Rao Amarthaluru | Independent Director |
| Mr. Gobichettipalayam S Krishnan | Independent Director |
FAQ
What is the intrinsic value of Linde India Ltd?
Linde India Ltd's intrinsic value (as of 17 October 2025) is 5190.98 which is 15.65% lower the current market price of 6,154.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 52,470 Cr. market cap, FY2025-2026 high/low of 8,470/5,202, reserves of ₹3,694 Cr, and liabilities of 5,110 Cr.
What is the Market Cap of Linde India Ltd?
The Market Cap of Linde India Ltd is 52,470 Cr..
What is the current Stock Price of Linde India Ltd as on 17 October 2025?
The current stock price of Linde India Ltd as on 17 October 2025 is 6,154.
What is the High / Low of Linde India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Linde India Ltd stocks is 8,470/5,202.
What is the Stock P/E of Linde India Ltd?
The Stock P/E of Linde India Ltd is 119.
What is the Book Value of Linde India Ltd?
The Book Value of Linde India Ltd is 443.
What is the Dividend Yield of Linde India Ltd?
The Dividend Yield of Linde India Ltd is 0.07 %.
What is the ROCE of Linde India Ltd?
The ROCE of Linde India Ltd is 16.9 %.
What is the ROE of Linde India Ltd?
The ROE of Linde India Ltd is 12.3 %.
What is the Face Value of Linde India Ltd?
The Face Value of Linde India Ltd is 10.0.